Announcements Trials
Browse Landscape

Status

Completed 40Terminated 13Withdrawn 5Unknown 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Chromosome Aberrations 1Carcinogenesis 1

Interventions

Magnetic Resonance Spectroscopy 332Specimen Handling 331Radiotherapy 315Cyclophosphamide 298pembrolizumab 286Cisplatin 270Carboplatin 247Drug Therapy 238Blood Specimen Collection 234Biopsy 203Bevacizumab 185Gemcitabine 181venetoclax 177Radiosurgery 170Oxaliplatin 164Capecitabine 163fludarabine 161Paclitaxel 158Nivolumab 157Standard of Care 135Surveys and Questionnaires 132Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 123Rituximab 113Docetaxel 112tislelizumab 111Cytarabine 106toripalimab 101Radiation 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × OTHER × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00280202 2025-10-24

Detection of Genetic Markers of Lung Cancer

University of Pittsburgh

Recruiting
6,000 enrolled
Thoracic

Chromosome Aberrations, Lung Neoplasms, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡